Instil Bio, Inc.TILNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Trend
Trending higher.
Left:
||||
Year-over-year research & development expense growth
Latest
35.36%
Near historical average
Average (22q)
38.77%
Historical baseline
Range
High:388.72%
Low:-80.76%
Volatility
1210.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 35.36% |
| Q2 2025 | 25.54% |
| Q1 2025 | 388.72% |
| Q4 2024 | 95.55% |
| Q3 2024 | -80.76% |
| Q2 2024 | -59.74% |
| Q1 2024 | 265.91% |
| Q4 2023 | -76.65% |
| Q3 2023 | 0.39% |
| Q2 2023 | -59.08% |
| Q1 2023 | -0.25% |
| Q4 2022 | -47.75% |
| Q3 2022 | -4.43% |
| Q2 2022 | 5.94% |
| Q1 2022 | -7.99% |
| Q4 2021 | 46.49% |
| Q3 2021 | 37.18% |
| Q2 2021 | 46.88% |
| Q1 2021 | 40.76% |
| Q4 2020 | 108.78% |
| Q3 2020 | 119.40% |
| Q2 2020 | 11.46% |
| Q1 2020 | 0.00% |